AEGR (AEGR) Stock Price, News & Analysis

Company Overview

Aegerion Pharmaceuticals, Inc. is a biopharmaceutical company engaged in the development and commercialization of therapies for patients with debilitating rare diseases. It operates through pharmaceuticals segment. Its products include lomitapide and metreleptin. Lomitapide is a small molecule microsomal triglyceride transfer protein (MTP) inhibitor. Lomitapide received marketing approval under the brand name Juxtapid (lomitapide) capsules from the United States Food and Drug Administration (FDA) as an adjunct to a low-fat diet and other lipid-lowering treatments. It also received marketing authorization for lomitapide in the European Union (EU) under the brand name LOJUXTA (lomitapide) hard capsules (LOJUXTA) as a treatment for HoFH in adults. Metreleptin is a recombinant human leptin analog that exerts its function by binding to and activating the human leptin receptor. Metreleptin is marketed in the United States under the brand name MYALEPT (metreleptin) for injection (MYALEPT).

Key Stats

• Today's Range: $1.97 to $1.97
• 50-Day Range: $1.97 to $1.97
• 52-Week Range: $1.23 to $10.85
• Volume: N/A
• Average Volume: 635,262 shs
• Market Capitalization: N/A
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

AEGR Stock Analysis - Frequently Asked Questions

How were AEGR's earnings last quarter?

AEGR (NASDAQ:AEGR) posted its quarterly earnings results on Monday, May, 16th. The biopharmaceutical company reported ($1.72) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.58) by $1.14. The firm's quarterly revenue was down 39.9% compared to the same quarter last year.

What other stocks do shareholders of AEGR own?

Based on aggregate information from My MarketBeat watchlists, some other companies that AEGR investors own include Bristol Myers Squibb (BMY), Allergan (AGN), Ford Motor (F), Gilead Sciences (GILD), NVIDIA (NVDA), Tesla (TSLA) and Ariad Pharmaceuticals (ARIA).

Company Calendar

• Last Earnings: 5/16/2016
• Today: 8/22/2025

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: N/A
• Industry: N/A
• Sub-Industry: Biotechnology
• Current Symbol: NASDAQ:AEGR
• CIK: 1338042
• Web: www.aegerion.com
• Phone: +1-617-5007867
• Fax: N/A
• Employees: N/A
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: N/A
• Free Float: N/A
• Market Cap: N/A
• Optionable: Not Optionable
• Beta: N/A